{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:40:36Z","timestamp":1780432836298,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008167","name":"Hennepin County Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1DA020024"],"award-info":[{"award-number":["UG1DA020024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN271201500065C"],"award-info":[{"award-number":["HHSN271201500065C"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN271201400028C"],"award-info":[{"award-number":["HHSN271201400028C"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.josat.2023.208987","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T05:37:03Z","timestamp":1676957823000},"page":"208987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial"],"prefix":"10.1016","volume":"151","author":[{"given":"Joy M.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Stotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda R.","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luba","family":"Yammine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.josat.2023.208987_bb0005","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/S0028-3908(00)00157-X","article-title":"The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: Implications for smoking cessation programs","volume":"39","author":"Almeida","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.josat.2023.208987_bb0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2015.01.036","article-title":"Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial","volume":"150","author":"Anderson","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.208987_bb0015","first-page":"CD010274","article-title":"Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders","volume":"11","author":"Apollonio","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.josat.2023.208987_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120581","article-title":"Tobacco-related mortality among persons with mental health and substance abuse problems","volume":"10","author":"Bandiera","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.josat.2023.208987_bb0025","first-page":"vii","article-title":"A dynamic cascade model of the development of substance-use onset","volume":"74","author":"Dodge","year":"2009","journal-title":"Monographs of the Society for Research in Child Development"},{"issue":"16","key":"10.1016\/j.josat.2023.208987_bb0030","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/sim.5728","article-title":"A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies","volume":"32","author":"Doros","year":"2013","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1016\/j.josat.2023.208987_bb0035","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.josat.2023.208987_bb0040","series-title":"Treating tobacco use and dependence: 2008 update","author":"Fiore","year":"2008"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.208987_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2007.08.020","article-title":"Nicotine and methamphetamine share discriminative stimulus effects","volume":"93","author":"Gatch","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.208987_bb0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2017.07.043","article-title":"Smoking cessation for substance misusers: A systematic review of qualitative studies on participant and provider beliefs and perceptions","volume":"180","author":"Gentry","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2023.208987_bb0055","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Archives of General Psychiatry"},{"issue":"16","key":"10.1016\/j.josat.2023.208987_bb0060","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2022.4790","article-title":"Trends in prevalence of cigarette smoking among US adults with major depression or substance use disorders, 2006\u20132019","volume":"327","author":"Han","year":"2022","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1016\/j.josat.2023.208987_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000508869","article-title":"Tobacco smoking rates in a National Cohort of people with substance use disorder receiving treatment","volume":"27","author":"Hayhurst","year":"2021","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1016\/j.josat.2023.208987_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jadohealth.2012.10.275","article-title":"Pilot randomized trial of bupropion for adolescent methamphetamine abuse\/dependence","volume":"52","author":"Heinzerling","year":"2013","journal-title":"J Adolesc Health"},{"issue":"11","key":"10.1016\/j.josat.2023.208987_bb0075","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/add.12636","article-title":"Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use","volume":"109","author":"Heinzerling","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2023.208987_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002130050872","article-title":"Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results","volume":"142","author":"Hutchison","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.josat.2023.208987_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.drugalcdep.2018.11.017","article-title":"Smoking cessation in the context of recovery from drug and alcohol problems: Prevalence, predictors, and cohort effects in a national U.S. Sample","volume":"195","author":"Kelly","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.208987_bb0090","first-page":"CD013308","article-title":"Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation","volume":"4","author":"Lindson","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.208987_bb6000","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addbeh.2016.10.012","article-title":"Impact of quitting smoking and smoking cessation treatment on substance use outcomes: An updated and narrative review","volume":"65","author":"McKelvey","year":"2017","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.josat.2023.208987_bb0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FBP.0000000000000349","article-title":"Decreases in smoking during treatment for methamphetamine-use disorders: Preliminary evidence","volume":"29","author":"McPherson","year":"2018","journal-title":"Behavioural Pharmacology"},{"issue":"4","key":"10.1016\/j.josat.2023.208987_bb0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/ADM.0000000000000218","article-title":"Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder","volume":"10","author":"Mooney","year":"2016","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.208987_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cpt.402","article-title":"Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial","volume":"100","author":"Mooney","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.josat.2023.208987_bb0110","series-title":"Reports of the surgeon general the health consequences of smoking\u201450 years of progress: A report of the surgeon general","author":"National Center for Chronic Disease","year":"2014"},{"key":"10.1016\/j.josat.2023.208987_bb0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2018.06.036","article-title":"Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment","volume":"195","author":"Passaro","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2023.208987_bb0120","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1037\/0022-006X.72.6.1144","article-title":"A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery","volume":"72","author":"Prochaska","year":"2004","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"3","key":"10.1016\/j.josat.2023.208987_bb0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.208987_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/tobaccocontrol-2018-054268","article-title":"Cigarette smoking among those with mental disorders in the US population: 2012\u20132013 update","volume":"29","author":"Smith","year":"2020","journal-title":"Tobacco Control"},{"key":"10.1016\/j.josat.2023.208987_bb0135","series-title":"Measuring alcohol consumption","first-page":"41","article-title":"Timeline follow-back: A technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"issue":"3","key":"10.1016\/j.josat.2023.208987_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/17512433.2014.909283","article-title":"Combination pharmacotherapies for stimulant use disorder: A review of clinical findings and recommendations for future research","volume":"7","author":"Stoops","year":"2014","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"5","key":"10.1016\/j.josat.2023.208987_bb0145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ntr\/ntv127","article-title":"A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery","volume":"18","author":"Thurgood","year":"2016","journal-title":"Nicotine and Tobacco Research"},{"issue":"2","key":"10.1016\/j.josat.2023.208987_bb0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa2020214","article-title":"Bupropion and naltrexone in methamphetamine use disorder","volume":"384","author":"Trivedi","year":"2021","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.208987_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/00952990802326280","article-title":"The impact of cigarette smoking on stimulant addiction","volume":"35","author":"Weinberger","year":"2009","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.josat.2023.208987_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cct.2011.09.018","article-title":"Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals","volume":"33","author":"Winhusen","year":"2012","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1016\/j.josat.2023.208987_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4088\/JCP.13m08449","article-title":"A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers","volume":"75","author":"Winhusen","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.josat.2023.208987_bb0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.drugalcdep.2013.09.019","article-title":"Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment","volume":"134","author":"Winhusen","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2023.208987_bb0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.amepre.2014.10.012","article-title":"Annual healthcare spending attributable to cigarette smoking: An update","volume":"48","author":"Xu","year":"2015","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2023.208987_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108883","article-title":"Decreased cocaine demand following contingency management treatment","volume":"226","author":"Yoon","year":"2021","journal-title":"Drug & Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:36Z","timestamp":1762652376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S2949875923000371"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.208987","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.208987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"208987"}}